These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

912 related articles for article (PubMed ID: 32407459)

  • 1. Risk Factors for Severe Disease and Efficacy of Treatment in Patients Infected With COVID-19: A Systematic Review, Meta-Analysis, and Meta-Regression Analysis.
    Zhang JJY; Lee KS; Ang LW; Leo YS; Young BE
    Clin Infect Dis; 2020 Nov; 71(16):2199-2206. PubMed ID: 32407459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 in hospitalised patients in Spain: a cohort study in Madrid.
    Rodriguez-Gonzalez CG; Chamorro-de-Vega E; Valerio M; Amor-Garcia MA; Tejerina F; Sancho-Gonzalez M; Narrillos-Moraza A; Gimenez-Manzorro A; Manrique-Rodriguez S; Machado M; Olmedo M; Escudero-Vilaplana V; Villanueva-Bueno C; Torroba-Sanz B; Melgarejo-Ortuño A; Vicente-Valor J; Herranz A; Bouza E; Muñoz P; Sanjurjo M
    Int J Antimicrob Agents; 2021 Feb; 57(2):106249. PubMed ID: 33259918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corticosteroid treatment in severe COVID-19 patients with acute respiratory distress syndrome.
    Liu J; Zhang S; Dong X; Li Z; Xu Q; Feng H; Cai J; Huang S; Guo J; Zhang L; Chen Y; Zhu W; Du H; Liu Y; Wang T; Chen L; Wen Z; Annane D; Qu J; Chen D
    J Clin Invest; 2020 Dec; 130(12):6417-6428. PubMed ID: 33141117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicentre study.
    Bartoletti M; Marconi L; Scudeller L; Pancaldi L; Tedeschi S; Giannella M; Rinaldi M; Bussini L; Valentini I; Ferravante AF; Potalivo A; Marchionni E; Fornaro G; Pascale R; Pasquini Z; Puoti M; Merli M; Barchiesi F; Volpato F; Rubin A; Saracino A; Tonetti T; Gaibani P; Ranieri VM; Viale P; Cristini F;
    Clin Microbiol Infect; 2021 Jan; 27(1):105-111. PubMed ID: 32971254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics of Egyptian male patients with COVID-19 acute respiratory distress syndrome.
    Doghish AS; Elkhatib WF; Hassan EA; Elkhateeb AF; Mahmoud EE; Ahmed MI; Khalil MAF
    PLoS One; 2021; 16(4):e0249346. PubMed ID: 33861750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality in COVID-19 patients with acute respiratory distress syndrome and corticosteroids use: a systematic review and meta-analysis.
    Hasan SS; Capstick T; Ahmed R; Kow CS; Mazhar F; Merchant HA; Zaidi STR
    Expert Rev Respir Med; 2020 Nov; 14(11):1149-1163. PubMed ID: 32734777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial.
    Payares-Herrera C; Martínez-Muñoz ME; Vallhonrat IL; de Molina RM; Torres MP; Trisan A; de Diego IS; Alonso R; Zafra R; Donaire T; Sánchez R; Rubio JJ; Duarte Palomino RF; Solá CA
    Trials; 2021 Jan; 22(1):9. PubMed ID: 33407777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analysis investigating the relationship between clinical features, outcomes, and severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia.
    Li J; He X; Yuan Yuan ; Zhang W; Li X; Zhang Y; Li S; Guan C; Gao Z; Dong G
    Am J Infect Control; 2021 Jan; 49(1):82-89. PubMed ID: 32540370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association of D-dimers with mortality, intensive care unit admission or acute respiratory distress syndrome in patients hospitalized with coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis.
    Bansal A; Singh AD; Jain V; Aggarwal M; Gupta S; Padappayil RP; Nadeem M; Joshi S; Mian A; Greathouse T; Wells D; Gupta M; Khan MZ
    Heart Lung; 2021; 50(1):9-12. PubMed ID: 33041057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections, influenza, community-acquired pneumonia and acute respiratory distress syndrome: a systematic review and meta-analysis.
    Ye Z; Wang Y; Colunga-Lozano LE; Prasad M; Tangamornsuksan W; Rochwerg B; Yao L; Motaghi S; Couban RJ; Ghadimi M; Bala MM; Gomaa H; Fang F; Xiao Y; Guyatt GH
    CMAJ; 2020 Jul; 192(27):E756-E767. PubMed ID: 32409522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prone Positioning in Moderate to Severe Acute Respiratory Distress Syndrome Due to COVID-19: A Cohort Study and Analysis of Physiology.
    Shelhamer MC; Wesson PD; Solari IL; Jensen DL; Steele WA; Dimitrov VG; Kelly JD; Aziz S; Gutierrez VP; Vittinghoff E; Chung KK; Menon VP; Ambris HA; Baxi SM
    J Intensive Care Med; 2021 Feb; 36(2):241-252. PubMed ID: 33380236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcomes of intravenous immunoglobulin therapy in COVID-19 related acute respiratory distress syndrome: a retrospective cohort study.
    Ali HS; Elshafei MS; Saad MO; Mitwally HA; Al Wraidat M; Aroos A; Shaikh N; Ananthegowda DC; Abdelaty MA; George S; Nashwan AJ; Mohamed AS; Khatib MY
    BMC Pulm Med; 2021 Nov; 21(1):354. PubMed ID: 34743710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver injury is independently associated with adverse clinical outcomes in patients with COVID-19.
    Yip TC; Lui GC; Wong VW; Chow VC; Ho TH; Li TC; Tse YK; Hui DS; Chan HL; Wong GL
    Gut; 2021 Apr; 70(4):733-742. PubMed ID: 32641471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Course and Outcome of COVID-19 Acute Respiratory Distress Syndrome: Data From a National Repository.
    El-Solh AA; Meduri UG; Lawson Y; Carter M; Mergenhagen KA
    J Intensive Care Med; 2021 Jun; 36(6):664-672. PubMed ID: 33685275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of increased BMI and obesity on the outcome of COVID-19 adult patients: A systematic review and meta-analysis.
    Soeroto AY; Soetedjo NN; Purwiga A; Santoso P; Kulsum ID; Suryadinata H; Ferdian F
    Diabetes Metab Syndr; 2020; 14(6):1897-1904. PubMed ID: 33007661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early Improvement of Acute Respiratory Distress Syndrome in Patients With COVID-19 in the Intensive Care Unit: Retrospective Analysis.
    Zhan Z; Yang X; Du H; Zhang C; Song Y; Ran X; Zhang A; Yang M
    JMIR Public Health Surveill; 2021 Mar; 7(3):e24843. PubMed ID: 33630743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19-Associated Critical Illness-Report of the First 300 Patients Admitted to Intensive Care Units at a New York City Medical Center.
    Chand S; Kapoor S; Orsi D; Fazzari MJ; Tanner TG; Umeh GC; Islam M; Dicpinigaitis PV
    J Intensive Care Med; 2020 Oct; 35(10):963-970. PubMed ID: 32812834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corticosteroids in adult respiratory distress syndrome - an inconvenient truth?
    Shulman R; Montanari C; Pinheiro I; Longobardo A; Benhalm S; Polhill S; Singer M; Bellingan G; Arulkumaran N
    Int J Pharm Pract; 2021 Dec; 29(6):642-644. PubMed ID: 34469546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized, double-blind, controlled trial of human anti-LIGHT monoclonal antibody in COVID-19 acute respiratory distress syndrome.
    Perlin DS; Neil GA; Anderson C; Zafir-Lavie I; Raines S; Ware CF; Wilkins HJ
    J Clin Invest; 2022 Feb; 132(3):. PubMed ID: 34871182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possibility of deterioration of respiratory status when steroids precede antiviral drugs in patients with COVID-19 pneumonia: A retrospective study.
    Shionoya Y; Taniguchi T; Kasai H; Sakuma N; Imai S; Shikano K; Takayanagi S; Yahaba M; Nakada TA; Igari H; Sakao S; Suzuki T
    PLoS One; 2021; 16(9):e0256977. PubMed ID: 34473766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.